Analyst Ratings for ArriVent BioPharma (AVBP)
AVBP Rating Summary
AVBP Price Target Summary
- Highest: $50.00 (Oppenheimer)
- Lowest: $33.00 (Goldman Sachs)
- Average: $41.86
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$41.86 (+78.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/22/2025 | Cantor Fitzgerald » Updated 1/16/2026 |
Li Watsek | New Coverage | Overweight (N/A) |
N/A (N/A) |
22.01 (23.43) |
6.45% | Details |
| 12/10/2025 | BTIG | Justin Zelin | New Coverage | Buy (N/A) |
45.00 (N/A) |
24.91 (23.43) |
-5.94% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
